TrendsMap
Finance

Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused - Endpoints News

EndpointsSeptember 1, 2026
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused - Endpoints News
Image: Endpoints

Three pa­tients died in No­var­tis tri­als of its CD19-di­rect­ed CAR-T treat­ment fol­low­ing a dan­ger­ous im­mune sys­tem re­sponse, and a sim­i­lar ther­a­py from Bris­tol My­ers Squibb

Where this sits on TrendsMap

This story hasn’t been tied to a specific state or province yet — it sits in our United States coverage. We hold 1541 finance stories in total, and 1 from Endpoints.

More FinanceMore from EndpointsOpen the map

This is a summary of reporting by Endpoints. Read the full story at the source.

Read full story
Back to home

Predictions (0)

No predictions yet on this story — be the first to start one.

Comments (0)

GU
posting as a guest

Create a free account to comment under your own name and earn Pulse.